Provided by Tiger Trade Technology Pte. Ltd.

OptimizeRx Corporation

8.57
+0.18002.15%
Post-market: 8.570.00000.00%19:30 EDT
Volume:224.86K
Turnover:1.94M
Market Cap:160.77M
PE:34.83
High:8.76
Open:8.55
Low:8.31
Close:8.39
52wk High:22.25
52wk Low:4.54
Shares:18.76M
Float Shares:14.50M
Volume Ratio:0.90
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2461
EPS(LYR):0.2700
ROE:3.68%
ROA:4.22%
PB:1.23
PE(LYR):31.74

Loading ...

OptimizeRx Outlook FY Adjusted Ebitda USD 21-25 Million

THOMSON REUTERS
·
Aug 13

OptimizeRx Corporation Expected to Post Earnings of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 11

OptimizeRx Schedules Q2 Earnings Conference Call

Reuters
·
Jul 29

Optimizerx Appoints Sarah Bast as Chief Marketing Officer

Reuters
·
Jul 23

Optimizerx Publishes Corporate Presentation on Ai-enabled Platform for Pharma-hcp-patient Engagement

Reuters
·
Jul 01

OptimizeRx shareholders approve 1 million-share increase to 2021 equity plan reserve

Reuters
·
Jun 13

OptimizeRx publishes corporate presentation on AI-driven healthcare marketing platform DAAP

Reuters
·
May 21

OptimizeRx partners with DeepIntent to integrate authenticated EHR network into DSP platform

Reuters
·
May 21

OptimizeRx (OPRX) Q1 Loss Tests Bullish Narrative Around Recently Improved Profitability

Simply Wall St.
·
May 14

OptimizeRx price target lowered to $11 from $20 at Lake Street

TIPRANKS
·
May 13

OptimizeRx Is Maintained at Equal-Weight by Stephens & Co.

Dow Jones
·
May 13

B. Riley Securities Remains a Buy on OptimizeRx (OPRX)

TIPRANKS
·
May 13

B. Riley Adjusts Price Target on OptimizeRx to $10 From $11, Maintains Buy Rating

MT Newswires Live
·
May 13

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), ProQR (PRQR) and OptimizeRx (OPRX)

TIPRANKS
·
May 13

OptimizeRx reports Q1 EPS 14c, consensus 0c

TIPRANKS
·
May 13

BRIEF-Optimizerx Corp - Enters Credit Agreement With Fifth Third Bank On May 7, 2026 - SEC Filing

Reuters
·
May 13

OptimizeRx Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

OptimizeRx Q1 Adj. EPS $0.14 Beats $0.00 Estimate, Sales $19.844M Beat $18.353M Estimate

Benzinga Earnings
·
May 13

OptimizeRx Q1 revenue beats analyst estimates

Reuters
·
May 13

OptimizeRx Corp - Credit Agreement Includes up to $25 Mln Incremental Accordion Feature - SEC Filing

THOMSON REUTERS
·
May 13